ClinicalTrials.gov
public full text
Public Domain
Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes#866173
- RZ358 Treatment for Congenital Hyperinsulinism#910870
- Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF#1072210
- Japan Long-term Safety for Tiotropium Plus Olodaterol#1126417
- A Study of MT-0551 in Patients With Systemic Sclerosis#1095268
Record · ID 407737
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive